Literature DB >> 9605743

Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil.

A Sugiyama1, F Maruta, T Ikeno, K Ishida, S Kawasaki, T Katsuyama, N Shimizu, M Tatematsu.   

Abstract

No previous report has demonstrated the relationship between Helicobacter pylori (HP) infection and gastric carcinogenesis in an experimental animal model. A total of 170 male Mongolian gerbils (MGs) were divided into nine groups (18 < or = n < or = 20 for each group). MGs of four groups were inoculated with HP before or after continuous N-methyl-N-nitrosourea (MNU) administration via the drinking water. Both intestinal-type and diffuse-type adenocarcinomas, including signet ring-cell carcinomas, were found at 40 weeks after the study commenced, but only in the HP inoculation groups with MNU exposure and not in the MNU alone or HP inoculation alone control groups. The present findings demonstrate that HP infection increases the incidence of MNU-induced adenocarcinoma of the glandular stomach in MGs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605743

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.

Authors:  T Goto; A Nishizono; T Fujioka; J Ikewaki; K Mifune; M Nasu
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Comparative analysis of colonization of Helicobacter pylori and glycolipids receptor density in Mongolian gerbils and mice.

Authors:  H Osawa; K Sugano; M Iwamori; M Kawakami; M Tada; M Nakao
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

3.  New tumor necrosis factor-alpha-inducing protein released from Helicobacter pylori for gastric cancer progression.

Authors:  Masami Suganuma; Miki Kurusu; Kaori Suzuki; Akira Nishizono; Kazunori Murakami; Toshio Fujioka; Hirota Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-23       Impact factor: 4.553

4.  Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils.

Authors:  Mitsushige Sugimoto; Tomoyuki Ohno; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

Review 5.  Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis.

Authors:  Masaaki Kodama; Kazunari Murakami; Ryugo Sato; Tadayoshi Okimoto; Akira Nishizono; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

6.  Intracellular VacA is a valuable marker to predict whether Helicobacter pylori induces progressive atrophic gastritis that is associated with the development of gastric cancer.

Authors:  Mikio Karita; Satoshi Teramukai; Satoru Matsumoto; Hidemi Shibuta
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

7.  First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic.

Authors:  Gökhan Selçuk Özbalcı; Saim Savaş Yürüker; İsmail Alper Tarım; Hamza Çınar; Ayfer Kamalı Polat; Aysu Başak Özbalcı; Kağan Karabulut; Kenan Erzurumlu
Journal:  Ulus Cerrahi Derg       Date:  2014-09-01

8.  Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.

Authors:  Taiji Akamatsu; Shinya Ichikawa; Sadahide Okudaira; Shuichi Yokosawa; Yugo Iwaya; Tomoaki Suga; Hiroyoshi Ota; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-08-19       Impact factor: 7.527

9.  Protein interaction network related to Helicobacter pylori infection response.

Authors:  Kyu Kwang Kim; Han Bok Kim
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 10.  Pathological issues of gastric and lower esophageal cancer: helicobacter pylori infection and its eradication.

Authors:  Takahiro Fujimori; Hitoshi Kawamata; Kazuhito Ichikawa; Yuko Ono; Yasuo Okura; Shigeki Tomita; Johji Imura
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.